Issue: April 2018
March 14, 2018
4 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: PCSK9 inhibitor access remains an issue, but assistance available
Issue: April 2018
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
ORLANDO, Fla. — In this Cardiology Today video exclusive, Seth J. Baum, MD, FASPC, discusses barriers faced by health care professions for the prescription of PCSK9 inhibitors.
While barriers remain, Baum, chief medical officer of Excel Medical Clinical Trials, clinical affiliate professor of biomedical science at Florida Atlantic University in Boca Raton and president of the American Society of Preventative Cardiology, highlights new resources that may help increase access to PCSK9 inhibitors, including the launch of a new app from the ASPC that was unveiled at the American College of Cardiology Scientific Session.
Watch the video for more.